The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Determinants of VLDL-triglycerides production
Abstract
PURPOSE OF REVIEW: Plasma free fatty acids (FFA) are major substrates for hepatic VLDL-triglycerides (VLDL-TG) production. In addition, it is a common belief that VLDL-TG production is a substrate driven process primarily determined by systemic FFA delivery. This review summarizes recent research of our understanding of the regulation of VLDL-TG production. RECENT FINDINGS: Recent studies have shown that increasing FFA flux is not inevitably associated with increased VLDL-TG production. Exercise induced increase in FFA flux resulting in unchanged VLDL-TG production in lean patients as well as in obese patients with increased hepatic fat despite exercise reduced hepatic fat content. With respect to the other inseparable conditions of insulin resistance and hyperinsulinemia, recent studies demonstrate that increased hepatic VLDL-TG production precedes the insulin resistance-associated impairment of the regulation of hepatic glucose production, whereas isolated chronic hyperinsulinemia (insulinoma) was not associated with increased VLDL-TG production. Insulin has been shown to have acute potent temporary suppressing effect on VLDL-TG production and new data demonstrates that increased glucagon reduces VLDL-TG production. Finally, recent studies indicate that sex hormones, oestrogen and testosterone, have no or very modest impact on VLDL-TG production. SUMMARY: Regulation of hepatic VLDL-TG production involves interplay between systemic FFA delivery, hormonal, and nutritional factors that act in concert with hepatic fatty acid handling to regulate short-term and long-term VLDL-TG production. The results of recent studies underscore that our current understanding of these relationships is complex and needs further research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When measured using radiolabeled VLDL particles, the adipose storage rates of VLDL-TG fatty acids appear to similar in men (91) and women (100).”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [100]
Citations
Cites
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972 · cited 1×
“Firstly, the actual release rate of FFA from the visceral fat depots is only making a limited contribution to the totality of FFA uptake by the liver [3] and secondly, there appears to be a much stronger association between VLDL-TG production and liver fat content than with visceral fat volumes [4].”
BackgroundSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · cited 1×
“Firstly, the actual release rate of FFA from the visceral fat depots is only making a limited contribution to the totality of FFA uptake by the liver [3] and secondly, there appears to be a much stronger association between VLDL-TG production and liver fat content than with visceral fat volumes [4].”
BackgroundSelf-citationFatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 1×
“However, the first part of this argument has recently been questioned [29] and it is important to consider the possibility that poorly”
BackgroundSelf-citationLewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 502 · cited 2×
“Later, studies have shown that infusion of intralipid/heparin, in order to raise plasma FFA, increases VLDL-TG and VLDL-apoB100 secretion [13].”
BackgroundIncreased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418 · cited 1×
“The question whether the increased VLDL-TG production results from chronic hyperinsulinaemia or from other factors associated with insulin resistance is beyond the scope of the present review but was recently reviewed [28].”
BackgroundPhysical Activity and Exercise in the Regulation of Human Adipose Tissue Physiology
Thompson, D., Karpe, F., Lafontan, M., & Frayn, K. (2012) · Physiological Reviews · doi:10.1152/physrev.00012.2011 · Cited by 402 · cited 1×
“During physical exercise there is a massive increase in FFA flux from adipose tissue [23].”
BackgroundSelf-citationParks, E. J., Krauss, R. M., Christiansen, M. P., Neese, R. A., & Hellerstein, M. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6572 · Cited by 349 · cited 1×
“Moreover, during prolonged increase in carbohydrate ingestion newly synthesized VLDLTG contains a progressively greater fraction of glucose-derived fatty acids [1], whereas the overall VLDL-TG production is unaltered [17], unless a hypercaloric carbohydrate diet is ingested, in which case, production increases [18].”
BackgroundHavel, R. J., Kane, J. P., Balasse, E. O., Segel, N., & Basso, L. V. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106422 · Cited by 336 · cited 1×
“[12] who used a combination of FFA tracer and splanchnic arteriovenous balance techniques to demonstrate that the net amount of FFA taken up in the splanchnic bed correlates with the net splanchnic release of VLDL-TG into the hepatic vein in normolipidaemic and hyperlipidaemic patients.”
MethodFatty acid regulation of very low density lipoprotein production
Lewis, G. F. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00004 · Cited by 294 · cited 1×
“A common viewpoint, frequently stated in the literature, is that VLDL-TG production is a substratedriven process primarily determined by hepatic FFA delivery [11].”
Background
Research works printed but not linked: 2
- McQuaid, 2011, Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition D, iabetes, 60, 47
- Sondergaard, 2011, Impaired postprandial suppression of endogenous VLDL-TG secretion in type 2 diabetic men., Diabetes, 60, A190
Cited by
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
Animal models of metabolic syndrome: a review
Wong, S. K., Chin, K.-Y., Suhaimi, F. H., Fairus, A., & Ima-Nirwana, S. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0123-9 · Cited by 371
“Plasma free fatty acids are major substrates for hepatic VLDLtriglycerides production [53].”
BackgroundMetabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315
Causes and consequences of hypertriglyceridemia
Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239
“Liver triglyceride is derived from a number of sources, uptake of fatty acids from the bloodstream (especially that released from visceral fat depots), release of fatty acids from stored triglyceride in cytoplasmic lipid droplets, uptake and hydrolysis of chylomicron remnants, and de novo lipogenesis (34, 35, 37, 78,…”
BackgroundQuispe, R., Manalac, R. J., Faridi, K. F., Blaha, M. J., Toth, P. P., Kulkarni, K. R., Nasir, K., Virani, S. S., Banach, M., Blumenthal, R. S., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.057 · Cited by 171
“These findings may be explained by the higher concentration of VLDL-C present in hypertriglyceridemic settings [48], compared with normotriglyceridemic settings.”
ResultGeerling, J. J., Boon, M. R., van der Zon, G. C., van den Berg, S. A. A., van den Hoek, A. M., Lombès, M., Princen, H. M. G., Havekes, L. M., Rensen, P. C. N., & Guigas, B. (2014) · Diabetes · doi:10.2337/db13-0194 · Cited by 167
“Hepatic VLDLTG production is mostly driven by intracellular substrate availability resulting from both FA uptake from the circulation and the balance between de novo lipogenesis and mitochondrial FA b-oxidation in the liver (33).”
BackgroundPramfalk, C., Pavlides, M., Banerjee, R., McNeil, C. A., Neubauer, S., Karpe, F., & Hodson, L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2649 · Cited by 138
“duction and can be influenced by a number of hormonal and nutritional factors (8).”
BackgroundSelf-citationInfluence of Dietary Macronutrients on Liver Fat Accumulation and Metabolism
Parry, S. A., & Hodson, L. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000524 · Cited by 155
Update on the molecular biology of dyslipidemias
Ramasamy, I. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.033 · Cited by 154
Jácome-Sosa, M., & Parks, E. J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000080 · Cited by 134
“A greater availability of plasma NEFA does not necessarily contribute to significantly greater VLDL-triglyceride secretion [57].”
BackgroundEmerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
Huang, J.-K., & Lee, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084300 · Cited by 130
Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D
Abu‐Farha, M., Al‐Khairi, I., Cherian, P., Chandy, B., Devarajan, S., Alhubail, A., Al-Refaei, F. H., Alterki, A., & Abubaker, J. A. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0337-x · Cited by 109
Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
Keirns, B. H., Sciarrillo, C. M., Koemel, N. A., & Emerson, S. R. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.73 · Cited by 86
“noted that the majority of free fatty acids reaching the liver are derived from peripheral depots((130,131)).”
BackgroundTherapeutic potential of herbal medicine for the management of hyperlipidemia: latest updates
Rauf, A., Akram, M., Anwar, H., Daniyal, M., Munir, N., Bawazeer, S., Bawazeer, S. S., Ребезов, М. Б., Bouyahya, A., Shariati, M. A., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-19733-7 · Cited by 108
“High cholesterol level has been seen in diabetes mellitus and hypothyroidism (Nielsen and Karpe, 2012).”
BackgroundNa, L., Zhang, Q., Jiang, S., Du, S., Zhang, W., Li, Y., Sun, C., & Niu, Y. (2015) · Scientific Reports · doi:10.1038/srep10344 · Cited by 82
Hodson, L., Banerjee, R., Rial, B., Arlt, W., Adiels, M., Borén, J., Marinou, K., Fisher, C., Mostad, I. L., STRATTON, I. M., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002258 · Cited by 84
Self-citationWang, Y., Ding, W., & Li, T. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.005 · Cited by 81
“Hepatic VLDL secretion rate is controlled by both hepatic fat content and ApoB100 availability (58).”
BackgroundDysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism
Nagarajan, S. R., Cross, E., Sanna, F., & Hodson, L. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003761 · Cited by 70
How does protein misfolding in the endoplasmic reticulum affect lipid metabolism in the liver?
Wang, S., & Kaufman, R. J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000056 · Cited by 58
“The most lipid-rich forms of secreted lipoprotein particles are VLDLs, which are assembled in the ER prior to trafficking to the Golgi [20].”
BackgroundInfluentialJohnston, L., Harris, S. B., Retnakaran, R. R., Giacca, A., Liu, Z., Bazinet, R. P., & Hanley, A. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4534-6 · Cited by 56
Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review
Carvalho, L. M. L., dos Reis, F. M., Cândido, A. L., Nunes, F. F. C., Ferreira, C. N., & Gomes, K. B. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0026 · Cited by 55
“PAI-1 has a positive correlation with glycemia, BMI, abdominal circumference, HOMA-IR, VLDL-c, LAP, triglycerides, vitamin D and soluble vascular cell adhesion molecule-1 (sVCAM-1) levels (Sales et al. 2013).”
BackgroundDiet-Induced Rabbit Models for the Study of Metabolic Syndrome
Lozano, W. M., Arias-Mutis, O. J., Calvo, C. J., Chorro, F. J., & Zarzoso, M. (2019) · Animals · doi:10.3390/ani9070463 · Cited by 53
“major substrate for the production of VLDL and LDL in the liver [40].”
BackgroundImpaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease
Poulsen, M. K., Nellemann, B., Stødkilde-Jørgensen, H., Pedersen, S. B., Grønbæk, H., & Nielsen, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3476 · Cited by 39
Self-citationGreen, C., Pramfalk, C., Morten, K., & Hodson, L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00192.2014 · Cited by 40
Smith, G. I., Reeds, D. N., Okunade, A. L., Patterson, B. W., & Mittendorfer, B. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4470 · Cited by 37
Straat, M. E., Jurado‐Fasoli, L., Ying, Z., Nahon, K. J., Janssen, L. G. M., Boon, M. R., Grabner, G. F., Kooijman, S., Zimmermann, R., Giera, M. A., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104349 · Cited by 40
“42,43 To evaluate whether intracellular lipolysis is crucial for the cold-induced increase in TAG species, we performed a mechanistic study assessing the effect of blocking ATGL by Atglistatin during cold exposure.”
BackgroundCosta, D. N., Santosa, S., & Jensen, M. D. (2025) · Physiological Reviews · doi:10.1152/physrev.00008.2024 · Cited by 34
MicroRNA-192* impairs adipocyte triglyceride storage
Mysore, R., Zhou, Y., Sädevirta, S., Savolainen-Peltonen, H. M., Haridas, P. A. N., Soronen, J., Leivonen, M., Sarin, A., Fischer‐Posovszky, P., Wabitsch, M., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.12.019 · Cited by 41
Lim, Y., Yoo, S., Lee, S. A., Chin, S. O., Heo, D., Moon, J. C., Moon, S., Boo, K., Kim, S. T., Seo, H. M., et al. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.2.208 · Cited by 41
El-Desoky, N. I., Hashem, N. M., Elkomy, A. G., & Abo-Elezz, Z. R. (2022) · Animals · doi:10.3390/ani12060764 · Cited by 39
“The hepatocytes use FAs as precursors for synthesizing essential energyyielding metabolites, such as triglycerides [11], and are used as an energy substrate by oocytes and embryos [12].”
Backgroundvan der Kolk, B. W., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2016) · Diabetologia · doi:10.1007/s00125-016-4104-3 · Cited by 34
“This increase in adipose tissue NEFA output might lead to increased hepatic VLDL-TAG production and elevated plasma TAG concentrations [15, 16].”
BackgroundWang, J., Qin, Z. H., Wang, Z., Shi, D., Liu, Y., Zhao, Y., Yang, L., Cheng, W.-J., & Zhou, Y.-J. (2018) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2018.02.011 · Cited by 30
Rojas, J. M., Bruinstroop, E., Printz, R. L., Alijagic-Boers, A., Foppen, E., Turney, M. K., George, L., Beck‐Sickinger, A. G., Kalsbeek, A., & Niswender, K. D. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.01.004 · Cited by 31
“[26]).”
Chronic inflammatory arthritis drives systemic changes in circadian energy metabolism
Downton, P. J., Sanna, F., Maidstone, R. J., Poolman, T. M., Hayter, E. A., Dickson, S. H., Ciccone, N. A., Early, J. O., Adamson, A. D., Spiller, D. G., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112781119 · Cited by 31
Physiological Responses to Hypoxia on Triglyceride Levels
Morin, R., Goulet, N., Mauger, J., & Imbeault, P. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730935 · Cited by 32
“In summary, hepatic VLDL synthesis is mainly substrate-driven and primarily determined by hepatic lipid availability, to which NEFA delivery appears to be the main contributor (Nielsen and Karpe, 2012).”
BackgroundCholesterol-Lowering Activity of Soy-Derived Glyceollins in the Golden Syrian Hamster Model
Huang, H., Xie, Z., Boué, S. M., Bhatnagar, D., YOKOYAMA, W. H., Yu, Q., & Wang, T. T. Y. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf400557p · Cited by 25
A network analysis of depressive symptoms and metabolomics
Rydin, A. O., Milaneschi, Y., Quax, R., Li, J., Bosch, J. A., Schoevers, R. A., Giltay, E. J., Penninx, B. W. J. H., & Lamers, F. (2023) · Psychological Medicine · doi:10.1017/s0033291723001009 · Cited by 23
“Mittendorfer, Yoshino, Patterson, & Klein, 2016; Nielsen & Karpe, 2012), indicating that BMI might be on the causal pathway.”
BackgroundGhodsi, S., Meysamie, A., Abbasi, M., Ghalehtaki, R., Esteghamati, A., Malekzadeh, M. M., Asgari, F., & Gouya, M. M. (2017) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-017-0306-6 · Cited by 26
“Increased influx of peripheral free fatty acids into the liver, induced production of VLDL, diminished performance of lipoprotein lipase and increased transportation of particles have been suggested as underlying mechanisms [21, 37].”
BackgroundIncreased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes
Andersen, I. R., Søndergaard, E., Sørensen, L. P., Nellemann, B., Gormsen, L. C., Jensen, M. D., & Nielsen, S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2979 · Cited by 21
“Because the majority of FA for VLDL-TG turnover are derived from plasma FFA released from subcutaneous fat (32), a high VLDL-TG turnover may actively augment the transfer of FA from adipose tissue to muscle.”
BackgroundSelf-citationSystemic Free Fatty Acid Disposal Into Very Low-Density Lipoprotein Triglycerides
Koutsari, C., Mundi, M. S., Ali, A. H., Patterson, B. W., & Jensen, M. D. (2013) · Diabetes · doi:10.2337/db12-1557 · Cited by 21
“This observation agrees with the view of Nielsen and Karpe (52) that regulation of VLDL-TG secretion is complex in that it involves interplay between hepatic FFA delivery, hepatic fatty acid partitioning, hormonal, and nutritional factors.”
Gut Microbiota and Serum Metabolome in Elite Cross-Country Skiers: A Controlled Study
Hintikka, J. E., Munukka, E., Valtonen, M., Luoto, R., Ihalainen, J. K., Kallonen, T., Waris, M. E., Heinonen, O. J., Ruuskanen, O., & Pekkala, S. (2022) · Metabolites · doi:10.3390/metabo12040335 · Cited by 25
“torques group did not associate with serum triglycerides in our study, we found the genus, along with Lachnospiraceae UCG-008, to be positively associated with total cholesterol, small VLDLs and large LDLs, which are mediators in hyperlipidemia [36,37].”
BackgroundThe essential functions of endoplasmic reticulum chaperones in hepatic lipid metabolism
Zhang, L., & Wang, H. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.03.016 · Cited by 21
Struwe, M. A., Scheidig, A. J., & Clement, B. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105306 · Cited by 23
“VLDL is secreted from hepatocytes to supply other tissues with triglycerides and is regulated by insulin (180).”
BackgroundSmith, G. I., Magkos, F., Reeds, D. N., Okunade, A. L., Patterson, B. W., & Mittendorfer, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1786 · Cited by 20
“with changes in hepatic VLDL-TG secretion (3, 47), most”
BackgroundKinetics and utilization of lipid sources during acute exercise and acipimox
Nellemann, B., Søndergaard, E., Jensen, J., Pedersen, S. B., Jessen, N., Jørgensen, J. O. L., & Nielsen, S. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00043.2014 · Cited by 20
“Regulation of VLDL-TG metabolism includes both substrate availability and endocrine control (28), and the additional effects of exercise are not fully understood.”
BackgroundSelf-citationTargeted Metabolomics Analysis on Obstructive Sleep Apnea Patients after Multilevel Sleep Surgery
Alterki, A., Joseph, S., Thanaraj, T. A., Al‐Khairi, I., Cherian, P., Channanath, A. M., Devarajan, S., Ebrahim, M. A. K., Ibrahim, A., Tiss, A., et al. (2020) · Metabolites · doi:10.3390/metabo10090358 · Cited by 18
“LPL is responsible for the hydrolysis of TG from TG-rich chylomicrons and VLDL to generate energy [48,49].”
BackgroundChen, Y., Lei, K., Liu, Y., Liu, J., Wei, K., Guo, J., & Su, Z. (2025) · Biomolecules · doi:10.3390/biom15070990 · Cited by 27
“However, high plasma NEFA levels or concentrations do not necessarily significantly contribute to increased VLDL–triglyceride secretion [166].”
Diakoumakou, O., Hatzigeorgiou, G., Gontoras, N., Boutsikou, M., Kolovou, V., Mavrogeni, S. I., Giannakopoulou, V., & Kolovou, G. D. (2014) · Cholesterol · doi:10.1155/2014/109263 · Cited by 20
“The circulating plasma TGs are formed mainly from two major sources: intestinally derived chylomicrons (CMs) and hepatically derived very low density lipoproteins (VLDL) [22].”
BackgroundCold-Induced Thermogenesis Shows a Diurnal Variation That Unfolds Differently in Males and Females
Straat, M. E., Martínez‐Téllez, B., Mishre, A. S. D. S., Verkleij, M. M. A., Kemmeren, M., Pelsma, I. C. M., Alcántara, J. M. A., Méndez-Gutiérrez, A., Kooijman, S., Boon, M. R., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac094 · Cited by 17
Zhang, F., Zhao, Y., Wang, Y., Wang, H., Guo, Y., & Xiong, B. (2021) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2021.115185 · Cited by 18
Insulin regulation of regional lipolysis in upper-body obese and lean humans
Nielsen, S., & Jensen, M. D. (2024) · JCI Insight · doi:10.1172/jci.insight.175629 · Cited by 15
“Specifically, and impaired ability of insulin to suppress adipose tissue lipolysis (3) and hepatic glucose and triglyceride secretion (4) and to promote glucose disposal in peripheral tissues has been well described.”
BackgroundSelf-citationHeebøll, S., Risikesan, J., Ringgaard, S., Kumarathas, I., Sandahl, T. D., Grønbæk, H., Søndergaard, E., & Nielsen, S. (2022) · Diabetes · doi:10.2337/db22-0313 · Cited by 17
“The effects on hepatic glucose and VLDL-TG metabolism are modulated by differences in insulin concentration and efficacy and by substrate availability (37).”
BackgroundSelf-citationDesign, synthesis and anti-NASH effect evaluation of novel GFT505 derivatives in vitro and in vivo
Xiang, C., Chen, X., Yao, J., Yang, N., Yu, J., Qiu, Q., Zhang, S., Kong, X., Zhao, L., Fan, Z., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115510 · Cited by 16
The Effect of Acute Continuous Hypoxia on Triglyceride Levels in Constantly Fed Healthy Men
Mauger, J., Chassé, É., Mahat, B., Lindon, C., Bordenave, N., & Imbeault, P. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00752 · Cited by 13
“Interestingly, despite no changes in plasma TG concentrations, our previous studies reported significant increases (∼+35%) in circulating nonesterified fatty acids, which is an important contributor to hepatic lipogenesis and very-low density lipoprotein production (Nielsen and Karpe, 2012).”
BackgroundGoulet, N., Marcoux, C., Bourgon, V., Morin, R., Mauger, J., Amaratunga, R., & Imbeault, P. (2024) · The Journal of Physiology · doi:10.1113/jp285430 · Cited by 12
“…directly upregulates lipid biosynthesis in the liver (Geerling et al., 2014) and also stimulates intracellular lipolysis in adipose tissue (Weiszenstein et al., 2016), leading to increased non-esterified fatty acid release, which is the main precursor to VLDL production (Nielsen & Karpe, 2012).”
Bouaziz, A., Dib, A. L., Lakhdara, N., Kadja, L., Espigares, E., Moreno, E., Bouaziz, O., & Gagaoua, M. (2021) · Biology · doi:10.3390/biology10020131 · Cited by 13
“Fatty acids are also the main substrates for the production of Very Low-Density Lipoprotein (VLDL) and Low-Density Lipoprotein (LDL) in the liver [49].”
BackgroundCasquero, A. C., Berti, J. A., Teixeira, L. L. S., & Oliveira, H. C. F. (2017) · Lipids · doi:10.1007/s11745-017-4299-1 · Cited by 10
Siti, Z., Seoparjoo, A. M. I., & Shahrul, H. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01573 · Cited by 11
“Most of previous clinical studies highlight the role of VLDL in diseases [16, 17, 18].”
Higgins, P. B., Rodriguez, P. J., Voruganti, V. S., Mattern, V. L., Bastarrachea, R. A., Rice, K., Raabe, T. D., & Comuzzie, A. G. (2013) · American Journal of Physical Anthropology · doi:10.1002/ajpa.22357 · Cited by 12
“…availability free fatty acids (from increased adipose tissue lipolysis) for hepatic VLDL triglyceride production and can attenuate the suppression of de novo lipogenesis, resulting in elevated VLDL triglyceride concentrations in the presence of fasting hyperinsulinemia (Nielsen and Karpe, 2012).”
BackgroundJohnston, L., Liu, Z., Retnakaran, R. R., Zinman, B., Giacca, A., Harris, S. B., Bazinet, R. P., & Hanley, A. J. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p084970 · Cited by 12
Cortisol in metabolic syndrome
Mazgelytė, E., & Karčiauskaitė, D. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.06.008 · Cited by 24
Wilkins, J. T., Ning, H., Sniderman, A. D., Stone, N. J., Otvos, J. D., Jacobs, D. R., Shah, R. V., Murthy, V. L., Rana, J. S., Allen, N. B., et al. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100299 · Cited by 9
“15 resistance causes increases in VLDL particles and therefore increased total apoB(25-27).”
BackgroundNellemann, B., Christensen, B., Vissing, K., Thams, L., Sieljacks, P., Larsen, M. S., Jørgensen, J. O. L., & Nielsen, S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0333 · Cited by 9
Self-citationJohansen, R. F., Søndergaard, E., Linnebjerg, H., Garhyan, P., Lam, E. C. Q., Pørksen, N. K., Jacober, S. J., & Nielsen, S. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13087 · Cited by 9
“The hepatic effect of insulin includes both control of hepatic glucose production and release, as well as control of hepatic de novo lipogenesis and very-low-density lipoprotein (VLDL) production.(8) The peripheral effects include control of lipolysis, lipogenesis and glucose, and lipid disposal for storage and oxidat…”
BackgroundSelf-citationPalmeiro-Silva, Y. K., Aravena, R. I., Ossio, L., & Fluxá, J. P. (2020) · Nutrients · doi:10.3390/nu12082392 · Cited by 10
“Consequently, an increment of VA could lead to a higher TG transportation to and concentration in the liver, triggering an increase in VLDL-c production [65,70,71].”
BackgroundZhang, A., Sun, J., He, Y., Wang, N., & Tian, L. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13497 · Cited by 8
Role of growth hormone in hepatic and intestinal triglyceride-rich lipoprotein metabolism
Maraninchi, M., Calabrese, A., Nogueira, J. P., Castinetti, F., Mancini, J., Mourre, F., Pietri, L., Benamo, E., Albarel, F., Morange, I., et al. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.08.003 · Cited by 4
Gafer, J., Hassan, G. H. A. E.-R., Ghoneim, H. A. M., & Mahmoud, M. F. (2023) · European Journal of Veterinary Medicine · doi:10.24018/ejvetmed.2023.3.5.83 · Cited by 4
“employed as precursors for the production of vital energyproducing metabolites [13] and oocytes and embryos use it as”
MethodMetabolic Risk Factors in Young Men With Healthy Body Fat But Different Level of Physical Activity
Kęska, A., Tkaczyk, J., Malara, M., & Iwańska, D. (2022) · American Journal of Men s Health · doi:10.1177/15579883211070384 · Cited by 5
Grønbæk, H., Mellemkjær, A., Nielsen, S., & Magkos, F. (2023) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-23-552 · Cited by 4
“Hepatic DNL is directly related to circulating glucose and insulin concentrations and to intrahepatic triglyceride accumulation (7,9).”
BackgroundSelf-citationFang, J. X., Zou, H.-M., Meng, J., Yu, H., Hu, X., Gu, Q., Wang, S. J., & Liu, X. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100662 · Cited by 4
“In circulation, TG needs the help of lipoproteins to exist in the form of chylomicrons or VLDL, which are secreted by the intestine and liver, respectively (44).”
Mostad, I. L., & Grill, V. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad101 · Cited by 2
“Evidence indicates that hormones, such as estrogens, do affect the function of adipocyte tissues [21, 22].”
BackgroundFeng, X., Li, M., Liu, H., Higgins, P. B., Tang, Y., Cao, Y., Shen, J., Jin, S., & Ge, S. (2020) · NFS Journal · doi:10.1016/j.nfs.2020.03.001 · Cited by 5
Tissue-specific insulin resistance in human obesity: A physiological approach to lipid metabolism
van der Kolk (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180503bk · Cited by 2
Pathophysiological Mechanisms Linking Obstructive Sleep Apnea to Nonalcoholic Fatty Liver Disease
Dongol, E. M., Hamdan, F. R. A., Ahmed, O., Abdel-Aziz, R. H., Younes, M., & Toghan, R. (2025) · Sleep Medicine Research · doi:10.17241/smr.2025.02859 · Cited by 1
Detection and Treatment of Children and Adolescents with Dyslipidemia
Kwiterovich, P. O. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_5 · Cited by 1
Zhou, L., Yang, J.-M., Wang, M., Gao, Y., Zhang, S., Sun, Y., Wang, Q., Cui, J. G., & Li, Y. (2018) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2018.10.001 · Cited by 1
Efeito do pré-tratamento com óleo de peixe sobre o infarto agudo do miocárdio em ratos.
de Souza, A. L. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-10072014-145247 · Cited by 3
Effects of immunosuppressive drugs on human adipose tissue metabolism
Pereira, M. J. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Geerling, J. J., Boon, M. R., van der Zon, G. C., van den Hoek, A. M., Lombès, M., Havekes, L. M., & Guigas, B. (2013)
Роль статевого диморфізму у розвитку неалкогольної жирової хвороби печінки
Yahmur, V. B., Nedzvetska, N. V., & Kononenko, I. S. (2016) · GASTROENTEROLOGY · doi:10.22141/2308-2097.2.60.2016.74758
THE EFFECT OF ACUTE CONTINUOUS HYPOXIA ON POSTPRANDIAL LIPID METABOLISM
Chassé, É. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-344
“Plasma TG levels represent the production of TG-rich lipoproteins (TRLs) by both the liver (as very low density lipoproteins, or VLDLs) and the intestine (as chylomicrons (CM)), as well as the disposal of TRLs and their remnants in the periphery (Nielsen & Karpe, 2012; Williams, 2008).”
BackgroundDietary polyphenols: modulators of energy and substrate metabolism in obese humans
Most, J. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160115jm
Warnke (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180316iw
Nadia, F. S., Wati, D. A., Isnawati, M., Sulchan, M., & Afifah, D. N. (2020) · Jurnal Aplikasi Teknologi Pangan · doi:10.17728/jatp.5028
Fatty acid composition in four serum lipid fractions and the pathogenesis of diabetes
Johnston, L. (2017) · TSpace (University of Toronto)
Iqbal, D. T. M., Saputri, F. C., Mun’im, A., & Suswidiantoro, V. (2023) · Jurnal Aisyah Jurnal Ilmu Kesehatan · doi:10.30604/jika.v8is1.1692
Proposed mechanisms of action of serum triglyceride lowering by plant sterols and stanols
Oranje, R. P. A. (2014) · Utrecht University Repository (Utrecht University)
Goulet, N., Lyndon, S., Bohlen, A., Antunes, P., Beaudry, N., & Imbeault, P. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6135794
Very low-density lipoprotein and the human health
Bharadwaj, A., Taneja, M., Dubey, S., & Saxena, A. (2026) · World Journal of Experimental Medicine · doi:10.5493/wjem.v16.i1.117024
“Insulin-hampered VLDL production, along with insulin resistance, leads to increased and decreased production of VLDL, often associated with hypertriglyceridemia[39-42”
Dai, X., Ba, D., Gao, M., Liang, C., Zhang, X., Yu, H., Chai, X., & Wang, Y. (2026) · Pharmaceuticals · doi:10.3390/ph19040532
The regulation of intrahepatic fatty acid partitioning within the human liver: the effect of sex
Dennis, K. M. J. H., Start, C. A. T., Josh, D., & Hodson, L. (2026) · Clinical Science · doi:10.1042/cs20260180
Goulet, N., Lyndon, S., Bohlen, A., Antunes, P., Beaudry, N., & Imbeault, P. (2026) · Peer Community Journal · doi:10.24072/pcjournal.777
“The triglyceride content of VLDL reflects hepatic fatty acid availability, which is determined by both exogenous sources (e.g., dietary fat from chylomicron remnants) and endogenous pathways (e.g., de novo lipogenesis and non-esterified fatty acid [NEFA] delivery) (Nielsen & Karpe, 2012).”
Metadata
- Authors
- Nielsen, S., & Karpe, F.
- Affiliations
- Aarhus University Hospital (DK)
- Churchill Hospital (GB)
- Corresponding author
- Karpe, Fredrik
- Venue
- Current Opinion in Lipidology
- Published
- 2012-08
- Volume
- 23
- Issue
- 4
- Pages
- 321-326
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W1993594610
- Cited by
- 94
- References
- 41
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 9 · 2015: 10 · 2014: 9 · 2013: 6 · 2012: 1
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sundhed og Sygdom, Det Frie Forskningsråd
- British Heart Foundation
- Novo Nordisk Fonden
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- VLDL triglycerides, free fatty acids, physical activity, liver fat, insulin resistance, hyperinsulinemia, insulin, glucagon, sex hormones, estrogen, testosterone, hepatic glucose production
- MeSH terms
- Animals, Fatty Acids, Nonesterified, Glucagon, Hormones, Humans, Insulin, Lipoproteins, VLDL, Triglycerides, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.